MicroPort Announces HKEx Main Board Listing Details
Global Offering of 252,740,000 Shares
At between HK$4.60 and HK$6.10 Per Share
HONG KONG, 12 September 2010 – MicroPort Scientific Corporation ("MicroPort" or "the Company"), a leading developer, manufacturer and marketer of medical devices in China minimally invasive interventional products for the treatment of vascular diseases and disorders, today announced the details of its proposed listing on the Main Board of The Stock Exchange of Hong Kong Limited ("HKEx").
This website may store cookies on your browser. Cookies are mostly used to make the website work as you expect it to. No cookie will directly identify you, but it can give you a more personalized browsing experience.
MicroPort respects your privacy rights, so you can block some types of cookies. Technically non-essential cookies and tracking mechanisms, that enable us to provide you with customized offers (marketing cookies), are only used if you have given prior consent to such use.
By clicking “Save”, only the cookies you selected will be used. You can withdraw the consent that you granted here at any time by going to Cookies Settings.